All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for EPILEPSY FOUNDATION OF AMERICA · nonprofit organization

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Taxation/Internal Revenue Code

Support affordable access to health insurance including through extension of Enhanced Advanced Premium Tax Credits.

Health Issues

Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.

Bills named in this filing 4

S. 494
National Plan for Epilepsy Act
H.R. 1189
National Plan for Epilepsy Act
H.R. 9495
Department of Defense Appropriations Act, 2027
H.R. 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.